One of the issues that has come up again and again in prescription drug lawsuits is the fact that many pharmaceutical companies have promoted their drugs for off-label uses not approved by the Food and Drug Administration (FDA). Though doctors can generally prescribe medications as…
In January 2014, the FDA released a drug safety communication announcing they were investigating the risk of serious side effects—including stroke, heart attack, and death—in men taking testosterone replacement products. They released the warning in response to a couple of major studies that had ind
Health Canada has completed a safety review of Xarelto (rivaroxaban), a newer-generation anti-coagulant medication manufactured by Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson). According to a Summary Safety Review released on August 26, 2015, the department investigated the medication
In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federal Xarelto lawsuits into one court in the Eastern District of Louisiana before the Honorable Judge Fallon. Currently, about 400 cases are pending there. One of the cases recently filed involves a…
Express Scripts, the largest U.S. pharmacy benefit manager, has excluded Onglyza (saxagliptin), a type 2 diabetes medication, and Kombiglyze XR ata gliptin plus metformin, from insurance coverage. That means that patients using this drug may have to pay the full retail price for it. Why…
Over the past few years, health experts have been questioning the effectiveness of testosterone replacement drugs for helping men to improve their sexual function and quality of life. Though products like Androderm and AndroGel have become very popular, some studies have linked them with a…
On May 15, 2015, the Food and Drug Administration (FDA) released a drug safety communication warning doctors and patients about serious side effects associated with type 2 diabetes medication Invokana (canagliflozen), and other similar medications. Since that warning, Invokana attorneys have been in
An FDA advisory panel has recommended that Onglyza (saxagliptin), a type 2 diabetes medication, should have its warning label updated to indicate that it could increase risk of heart failure. Onglyza belongs to a class of drugs known as “dipeptidyl peptidase-4 (DDP-4) inhibitors.” Also called…
The number of Zofran lawsuits filed across the country continues to increase. Moms who took Zofran for morning sickness during pregnancy and then gave birth to babies with birth defects now seek to hold manufacturer GlaxoSmithKline (GSK) liable for medical expenses. Considering the growing litigatio
An FDA advisory panel has recommended that Onglyza (saxagliptin), a type 2 diabetes medication, should have its warning label updated to indicate that it could increase risk of heart failure. Onglyza belongs to a class of drugs known as “dipeptidyl peptidase-4 (DDP-4) inhibitors.” Also called…
In May 2015, the FDA warned that type 2 diabetes drugs like Invokana could have a potentially dangerous side effect: diabetic ketoacidosis (DKA). This is a serious condition in which the blood becomes too acidic, and can lead to complications like dehydration, coma, and even…
We’ve all seen direct-to-consumer advertisements for medications. They usually show people improving over a short period of time, and experiencing a much more vibrant and exciting life after taking the company’s drug. Though the side effects are usually listed, the overall messages in these advertis